Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Bone remodelling and bone loss are controlled by a balance between the tumour necrosis factor family molecule osteoprotegerin ligand (OPGL) and its decoy receptor osteoprotegerin (OPG). In addition, OPGL regulates lymph node organogenesis, lymphocyte development and interactions between T cells and dendritic cells in the immune system. The OPGL receptor, RANK, is expressed on chondrocytes, osteoclast precursors and mature osteoclasts. OPGL expression in T cells is induced by antigen receptor engagement, which suggests that activated T cells may influence bone metabolism through OPGL and RANK. Here we report that activated T cells can directly trigger osteoclastogenesis through OPGL. Systemic activation of T cells in vivo leads to an OPGL-mediated increase in osteoclastogenesis and bone loss. In a T-cell-dependent model of rat adjuvant arthritis characterized by severe joint inflammation, bone and cartilage destruction and crippling, blocking of OPGL through osteoprotegerin treatment at the onset of disease prevents bone and cartilage destruction but not inflammation. These results show that both systemic and local T-cell activation can lead to OPGL production and subsequent bone loss, and they provide a novel paradigm for T cells as regulators of bone physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RANKL is produced by numerous cell types including cells of the osteoblast lineage (46,47) and activated T cells (42,48,49).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
In the citing paper
“T Cells express both soluble and membrane-bound forms of RANKL (49,50), and both forms are implicated in focal bone erosions associated with inflammatory arthritis (26,49).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
In the citing paper
“Within the developed immune system, RANKL is expressed by T cells (42), RANK is expressed by dendritic cells (49), and OPG is expressed by B lymphocytes and dendritic cells (4,70).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
In the citing paper
“However, RANK and RANKL knockout mice had normal Peyer's patches and intact splenic architecture (49,62), indicating that the development of lymph nodes and secondary lymphoid organs can be differentially regulated.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
In the citing paper
“RANKL inhibition via recombinant OPG treatment also results in marked suppression of bone erosions and osteoclasts in several rodent models, including adjuvant arthritis (26,49,177,232,233), collagen-induced arthritis (26,181,233), and TNF-mediated arthritis (136, 234).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Self-citationOsteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Self-citationOPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 1×
“We show that: (1) p66 is serine phosphorylated upon treatment with hydrogen peroxide (H2O2) or irradiation with ultraviolet light; (2) ablation of p66 enhances cellular resistance to apoptosis induced by H2O2 or ultraviolet light; (3) a serinephosphorylation defective mutant of p66 cannot restore the normal stress res…”
BackgroundSelf-citationRAG-1-deficient mice have no mature B and T lymphocytes
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,931
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
Self-citationROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
Self-citationWong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
Cited by
Items 401–500 of 1,007
Monteiro, A. C., Leal, A. C., Gonçalves-Silva, T., Mercadante, A. C. T., Kestelman, F., Chaves, S. B., Azevedo, R. B., Monteiro, J. P., & Bonomo, A. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068171 · Cited by 122
Hsu, Y., Niu, T., Terwedow, H. A., Xu, X. P., Feng, Y., Li, Z., Brain, J. D., Rosen, C. J., Laird, N. M., & Xu, X. (2005) · Human Genetics · doi:10.1007/s00439-005-0062-4 · Cited by 121
“Systematically or locally activated T cells can directly trigger osteoclastogenesis through RANKL, and then reduce bone mass (Kong et al. 1999).”
BackgroundValverde, P., Kawai, T., & Taubman, M. A. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301213 · Cited by 110
The role of interleukin-1 in bone resorption in rheumatoid arthritis
Strand, V. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh202 · Cited by 114
“Several studies have shown increased expression of RANKL mRNA in cultured synovial fibroblasts and T cells from patients with RA [25–27].”
BackgroundGreisen, S. R., Rasmussen, T., Stengaard‐Pedersen, K., Hetland, M. L., Hørslev‐Petersen, K., Hvid, M., & Deleuran, B. W. (2013) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2013.823517 · Cited by 111
Nakamura, T., Kukita, T., Shobuike, T., Nagata, K., Wu, Z., Ogawa, K., Hotokebuchi, T., Kohashi, O., & Kukita, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5809 · Cited by 117
RANK-Fc: A therapeutic antagonist for RANK-L in myeloma
Sordillo, E. M., & Pearse, R. N. (2003) · Cancer · doi:10.1002/cncr.11134 · Cited by 114
Chiang, E. Y., Li, T., Jeet, S., Peng, I., Zhang, J., Lee, W. P., DeVoss, J., Caplazi, P., Chen, J., Warming, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14644 · Cited by 108
TNF ligands and receptors in autoimmunity: an update
Mackay, F., & Kalled, S. L. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00407-7 · Cited by 117
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy
Herman, S., Krönke, G., & Schett, G. A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.04.001 · Cited by 122
Cytokines in the Pathogenesis of Rheumatoid Arthritis and Collagen-Induced Arthritis
Lubberts, E., & van den Berg, W. B. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0171-8_11 · Cited by 121
The immune system, bone and RANKL
Guerrini, M. M., & Takayanagi, H. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.003 · Cited by 129
Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases
Coury, F., Peyruchaud, O., & Machuca‐Gayet, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00679 · Cited by 115
HIV Infection—A Risk Factor for Osteoporosis
Thomas, J., & Doherty, S. M. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200307010-00001 · Cited by 107
The KRN mouse model of inflammatory arthritis
Kyburz, D., & Corr, M. (2003) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0131-5 · Cited by 118
“These results support previous findings in adjuvant arthritis in mice treated with osteoprotegerin [19].”
ResultPATHWAYS BY WHICH INTERLEUKIN 17 INDUCES ARTICULAR CARTILAGE BREAKDOWN IN VITRO AND IN VIVO
Cai, L., Yin, J., Starovasnik, M. A., Hogue, D. A., Hillan, K. J., Mort, J. S., & Filvaroff, E. H. (2001) · Cytokine · doi:10.1006/cyto.2001.0939 · Cited by 123
Dalbeth, N., Pool, B., Smith, T., Callon, K. E., Lobo, M., Taylor, W. J., Jones, P. B., Cornish, J., & McQueen, F. M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3123 · Cited by 115
Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis
Xu, S., Wang, Y., Lu, J., & Xu, J. (2011) · Rheumatology International · doi:10.1007/s00296-011-2175-5 · Cited by 114
NAGASAWA, T., KOBAYASHI, H., KIJI, M., ARAMAKI, M., MAHANONDA, R., KOJIMA, T., MURAKAMI, Y., SAITO, M., MOROTOME, Y., & ISHIKAWA, I. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01990.x · Cited by 106
Bugatti, S., Caporali, R. F., Manzo, A., Vitolo, B., Pitzalis, C., & Montecucco, C. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21377 · Cited by 116
Rationale for the role of osteoclast‐like cells in arterial calcification
Doherty, T. M., Uzui, H., Fitzpatrick, L. A., Tripathi, P. V., Dunstan, C. R., Asotra, K., & Rajavashisth, T. B. (2002) · The FASEB Journal · doi:10.1096/fj.01-0898hyp · Cited by 107
Xing, L., Venegas, A. M., Chen, A. Y.-C., Garrett-Beal, L. J., Boyce, B. F., VARMUS, H. E., & Schwartzberg, P. L. (2001) · Genes & Development · doi:10.1101/gad.840301 · Cited by 111
“In bone, this may be particularly useful for the treatment both of osteoporosis and of rheumatoid arthritis, where blocking RANKL activity has been found to decrease bone destruction in animal models (Kong et al. 1999a).”
BackgroundIbáñez, L., Rouleau, M., Wakkach, A., & Blin-Wakkach, C. (2019) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.02.008 · Cited by 103
Deuell, K. A., Callegari, A., Giachelli, C. M., Rosenfeld, M. E., & Scatena, M. (2012) · Journal of Vascular Research · doi:10.1159/000341216 · Cited by 121
Bandow, K., Nishikawa, Y., Ohnishi, T., Kakimoto, K., Soejima, K., Iwabuchi, S., Kuroe, K., & Matsuguchi, T. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20944 · Cited by 120
“While some activated T cells express a significant amount of RANKL and potently induce osteoclastogenesis (Kong et al., 1999), they also secrete IFN-g, which inhibits RANK-mediated signals in osteoclasts by promoting the degradation of TRAF6, an essential downstream component of RANK (Takayanagi et…”
BackgroundTranscriptional Mechanisms of Bone Morphogenetic Protein-induced Osteoprotegrin Gene Expression
Wan, M., Shi, X., Feng, X., & Cao, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006918200 · Cited by 119
Capparelli, C., Morony, S., Warmington, K., Adamu, S., Lacey, D., Dunstan, C. R., Stouch, B., Martin, S., & Kostenuik, P. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.852 · Cited by 103
“The therapeutic benefits of rOPG have been demonstrated in a variety of preclinical models of bone disease, including ovariectomy-induced osteoporosis,((7,18)) rheumatoid arthritis,((19)) skeletal unloading,((20)) bone metastasis,((21,22)) and humoral hypercalcemia of malignancy.”
BackgroundSelf-citationChang, I., Tsai, C., & Chang, Y. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32839 · Cited by 119
Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation
Smith, B. J., Lerner, M. R., Bu, S. Y., Lucas, E. A., Hanas, J. S., Lightfoot, S. A., Postier, R. G., Bronze, M. S., & Brackett, D. J. (2005) · Bone · doi:10.1016/j.bone.2005.09.008 · Cited by 103
“bone loss observed in the current study was less pronounced than the osteopenia reported in animal models of rheumatoid arthritis [28,40] and inflammation-mediated bone loss [41] but may be more indicative of the skeletal response to persistent elevation of proinflammatory mediators over time.”
MethodResultDanks, L., & Takayanagi, H. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt049 · Cited by 119
Neve, A., Corrado, A., & Cantatore, F. P. (2013) · Clinical and Experimental Medicine · doi:10.1007/s10238-013-0249-2 · Cited by 104
Regulation of bone by the adaptive immune system in arthritis
Okamoto, K., & Takayanagi, H. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3323 · Cited by 119
Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts
Baum, R., & Gravallese, E. M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8515-6 · Cited by 101
Ahuja, S. S., Zhao, S., Bellido, T., Plotkin, L. I., Jimenez, F., & Bonewald, L. F. (2003) · Endocrinology · doi:10.1210/en.2002-221136 · Cited by 101
Roles for NF-κB and c-Fos in osteoclasts
Boyce, B. F., Yamashita, T., Yao, Z., Zhang, Q., Li, F., & Xing, L. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf03026317 · Cited by 109
Shen, P.-C., Wu, C., Jou, I., Lee, C., Juan, H.-L., Lee, P.-J., Chen, S.-H., & Hsieh, J. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.02.014 · Cited by 102
Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis
Lawlor, K. E., Campbell, I. K., O’Donnell, K., Wu, L., & Wicks, I. P. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200102)44:2<266::aid-anr43>3.0.co;2-g · Cited by 53
Bolon, B., Carter, C., Daris, M., Morony, S., Capparelli, C., Hsieh, A., Mao, M., Kostenuik, P., Dunstan, C. R., Lacey, D. L., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0245 · Cited by 100
Self-citationJu, J. H., Cho, M.-L., Moon, Y.-M., Oh, H.-J., Park, J.-S., Jhun, J.-Y., Min, S.-Y., Cho, Y.-G., Park, K.-S., Yoon, C.-H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1507 · Cited by 100
Stolina, M., Adamu, S., Ominsky, M., Dwyer, D., Asuncion, F., Geng, Z., Middleton, S., Brown, H., Pretorius, J., Schett, G., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050601 · Cited by 99
“The essential role of RANKL in bone erosions has been clearly established in animals with AIA,(7) CIA,(21) serum-transfer arthritis,(18) and arthritis associated with overexpression of TNF- .”
BackgroundSelf-citationAlder, K. D., Lee, I., Munger, A. M., Kwon, H., Morris, M. T., Cahill, S. V., Back, J., Yu, K. E., & Lee, F. Y. (2020) · Bone · doi:10.1016/j.bone.2020.115568 · Cited by 110
Rifas, L., & Weitzmann, M. N. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24877 · Cited by 104
“T cell–derived production of tumor necrosis factor (TNF ) has been reported to play a critical role in ovariectomy-induced bone loss in mice (25), and T cell–derived RANKL is reported to be relevant in animal models of RA (26).”
BackgroundGrčević, D., Lee, S.-K., Marušić, A., & Lorenzo, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4231 · Cited by 99
RANK, RANKL and osteoprotegerin in arthritic bone loss
Bezerra, M. C., de Carvalho, J. F., Prokopowitsch, A. S., & Pereira, R. M. R. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000200004 · Cited by 115
“RANKL expressed on activated T-cells can trigger osteoclast activation and it is possible that RANKL/RANK might play a major role in inflammation-induced bone loss and joint destruction in arthritis (35).”
BackgroundInfluentialInflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review
Nevius, E., Gomes, A. C., & Pereira, J. P. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8520-9 · Cited by 112
Ofotokun, I., McIntosh, E. B., & Weitzmann, M. N. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0099-z · Cited by 107
IL-1β–driven osteoclastogenic Tregs accelerate bone erosion in arthritis
Levescot, A., Chang, M. H., Schnell, J. T., Nelson-Maney, N., Yan, J., Martínez‐Bonet, M., Grieshaber‐Bouyer, R., Lee, P. Y., Wei, K., Blaustein, R. B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141008 · Cited by 109
Chagraoui, H., Tulliez, M., Smayra, T., Komura, E., Giraudier, S., Yun, T. J., Lassau, N., Vainchenker, W., & Wendling, F. (2003) · Blood · doi:10.1182/blood-2002-09-2839 · Cited by 107
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.12.2274 · Cited by 98
Rifas, L., Arackal, S., & Weitzmann, M. N. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10436 · Cited by 98
Komatsu, N., & Takayanagi, H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00077 · Cited by 118
T Lymphocytes Influence the Mineralization Process of Bone
El Khassawna, T., Serra, A., Bucher, C. H., Petersen, A., Schlundt, C., Könnecke, I., Malhan, D., Wendler, S., Schell, H., Volk, H.-D., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00562 · Cited by 97
“Activated T cells are responsible for causing bone loss during rheumatoid arthritis (5) and postmenopausal”
BackgroundParticle disease. A comprehensive theory of periprosthetic osteolysis: a review.
Gallo, J., Kamínek, P., Ticha, V., Řiháková, P., & Ditmar, R. (2002) · Biomedical Papers · doi:10.5507/bp.2002.004 · Cited by 111
Experimental infection of warthos (Phacochoerus aethiopicus) with African swine fever virus.
Thomson, G. R., Gainaru, M. D., & van Dellen, A. F. (1980) · PubMed · Cited by 134
Ofotokun, I., Titanji, K., Vunnava, A., Roser‐Page, S., Vikulina, T., Villinger, F. J., Rogers, K. A., Sheth, A. N., Lahiri, C. D., Lennox, J. L., et al. (2016) · AIDS · doi:10.1097/qad.0000000000000918 · Cited by 104
Innate immunity as the trigger of systemic autoimmune diseases
Saferding, V., & Blüml, S. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102382 · Cited by 119
Hayer, S., Redlich, K., Korb, A., Hermann, S., Smolen, J. S., & Schett, G. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22313 · Cited by 105
Oda, T., Yoshie, H., & Yamazaki, K. (2003) · Oral Microbiology and Immunology · doi:10.1034/j.1399-302x.2003.180105.x · Cited by 109
Bloemen, V., Schoenmaker, T., de Vries, T. J., & Everts, V. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21971 · Cited by 96
Fakruddin, J. M., & Laurence, J. C. (2004) · Archives of Virology · doi:10.1007/s00705-004-0395-7 · Cited by 112
“Murine knock-out experiments have demonstrated that RANKL is essential to the regulation of bone resorption via induction of osteoclast differentiation [2, 19].”
BackgroundSarkar, S., Cooney, L. A., White, P., Dunlop, D. B., Endres, J., Jorns, J. M., Wasco, M. J., & Fox, D. A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2838 · Cited by 99
Mahamed, D. A., Marleau, A., Alnaeeli, M., Singh, B., Zhang, X., Penninger, J. M., & Teng, Y.-T. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1477 · Cited by 95
Self-citationKitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Nara, Y., Pramusita, A., Kinjo, R., Ma, J., Kanou, K., & Mizoguchi, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031481 · Cited by 116
“TNF-α plays a central role in inflammatory osteoclast formation and affects cells involved in osteoclast formation, including macrophages, stromal cells, and T cells expressing RANKL, which enables their osteoclastogenic potential [66,67].”
BackgroundOlson, N. C., Doyle, M. F., Jenny, N. S., Huber, S. A., Psaty, B. M., Kronmal, R. A., & Tracy, R. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071498 · Cited by 103
T cells: Critical bone regulators in health and disease
Pacifici, R. (2010) · Bone · doi:10.1016/j.bone.2010.04.611 · Cited by 94
LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis
Edwards, J., Sun, S. G., Locklin, R. M., Shipman, C. M., Adamopoulos, I. E., Athanasou, N. A., & Sabokbar, A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21821 · Cited by 100
“Activated T cells have been shown to directly induce osteoclastogenesis and bone resorption (31,32),”
BackgroundRole for osteoprotegerin in rheumatoid inflammation
Saidenberg-Kermanac’h, N., Cohen-Solal, M. E., Bessis, N., de Vernejoul, M. C., & Boissier, M. (2004) · Joint Bone Spine · doi:10.1016/s1297-319x(03)00131-3 · Cited by 100
“Il a également été montré que les cellules T activées sécrètent la forme soluble de RANKL dans le milieu de culture [15].”
BackgroundInfluentialRole of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders
Workgroup, O. B. O. T. E. R. O. (., Carrillo-López, N., Martínez-Arias, L., Fernández-Villabrille, S., Ruiz-Torres, M. P., Dusso, A., Cannata-Andía, J. B., Naves-Díaz, M., & Panizo, S. (2021) · Calcified Tissue International · doi:10.1007/s00223-020-00803-2 · Cited by 91
Galli, C., Zella, L. A., Fretz, J. A., Fu, Q., Pike, J. W., Weinstein, R. S., Manolagas, S. C., & O’Brien, C. A. (2008) · Endocrinology · doi:10.1210/en.2007-0734 · Cited by 93
The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization
Suh, W.-K., Wang, S. X., Jheon, A. H., Moreno, L., Yoshinaga, S. K., Ganss, B., Sodek, J., Grynpas, M. D., & Mak, T. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405259101 · Cited by 93
Dendritic Cells at the Osteo-Immune Interface: Implications for Inflammation-Induced Bone Loss
Alnaeeli, M., Park, J., Mahamed, D., Penninger, J. M., & Teng, Y.-T. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070314 · Cited by 93
Self-citationOxidized lipids enhance RANKL production by T lymphocytes: Implications for lipid-induced bone loss
Graham, L. S., Parhami, F., Tintut, Y., Kitchen, C. M. R., Demer, L. L., & Effros, R. B. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.011 · Cited by 94
Estrogen Regulation of Immune Cell Bone Interactions
Weitzmann, M. N., & Pacifici, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.030 · Cited by 97
Synovial macrophage-osteoclast differentiation in inflammatory arthritis
Danks, L., Sabokbar, A., Gundle, R., & Athanasou, N. A. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.10.916 · Cited by 95
Role of RANKL inhibition in osteoporosis
McClung, M. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2167 · Cited by 112
Expression Profiling of Lymphocyte Plasma Membrane Proteins
Peirce, M. J., Wait, R., Begum, S., Saklatvala, J., & Cope, A. P. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300064-mcp200 · Cited by 92
Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production
Oshita, K., Yamaoka, K., Udagawa, N., Fukuyo, S., Sonomoto, K., Maeshima, K., Kurihara, R., Nakano, K., Saito, K., Okada, Y., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30309 · Cited by 99
Itoh, K., Udagawa, N., Matsuzaki, K., Takami, M., Amano, H., Shinki, T., Ueno, Y., Takahashi, N., & Suda, T. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.9.1766 · Cited by 90
Cheng, X., Kinosaki, M., Takami, M., Choi, Y., Zhang, H., & Murali, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309690200 · Cited by 92
Proulx, S. T., Kwok, E., You, Z., Papuga, M. O., Beck, C. A., Shealy, D. J., Ritchlin, C. T., Awad, H. A., Boyce, B. F., Xing, L., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23128 · Cited by 90
Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection
Jones, D., Glimcher, L. H., & Aliprantis, A. O. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46262 · Cited by 91
Belibasakis, G. N., Johansson, A. S., Wang, Y., Chen, C., Kalfas, S., & Lerner, U. H. (2004) · Infection and Immunity · doi:10.1128/iai.73.1.342-351.2005 · Cited by 92
Okahashi, N., Inaba, H., Nakagawa, I., Yamamura, T., Kuboniwa, M., Nakayama, K., Hamada, S., & Amano, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1706-1714.2004 · Cited by 103
New immune connections in osteoclast formation
Takayanagi, H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05303.x · Cited by 97
T Cells Are Required for Orthodontic Tooth Movement
Yan, Y., Liu, F., Kou, X., Liu, D., Yang, R., Wang, X., Song, Y., He, D., Gan, Y.-H., & Zhou, Y. (2015) · Journal of Dental Research · doi:10.1177/0022034515595003 · Cited by 95
Ernst, C. W. O., Lee, J. E., Nakanishi, T., Karimbux, N. Y., Rezende, T. M. B., Stashenko, P., Seki, M., Taubman, M. A., & Kawai, T. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03318.x · Cited by 89
RANKL and RANK as novel therapeutic targets for arthritis
Nakashima, T., & Penninger, J. M. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200305000-00016 · Cited by 92
Self-citationPeng, X., Guo, W., Ren, T., Lou, Z., Lu, X., Zhang, S., Lu, Q., & Sun, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058361 · Cited by 94
RetractedThe role of T helper type 17 cells in inflammatory arthritis
Sarkar, S., Cooney, L. A., & Fox, D. A. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04016.x · Cited by 94
Auger, G. A., Pease, J. E., Shen, X., Xanthou, G., & Barker, M. D. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4<1003::aid-immu1003>3.0.co;2-p · Cited by 39
Arthritogenic alphaviruses: new insights into arthritis and bone pathology
Chen, W., Foo, S., Sims, N. A., Herrero, L. J., Walsh, N. C., & Mahalingam, S. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.005 · Cited by 106
Colucci, S. C., Brunetti, G., Cantatore, F. P., Oranger, A., Mori, G., Quarta, L., Cirulli, N., Mancini, L., Corrado, A., Grassi, F. R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2153 · Cited by 91
Pathogenesis of bone erosions in rheumatoid arthritis
Goldring, S. R. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200207000-00013 · Cited by 89
Nuclear Receptors in Bone Physiology and Diseases
Imai, Y., Youn, M.-Y., Inoue, K., Takada, I., Kouzmenko, A., & Kato, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2012 · Cited by 88
Opg, Rank, and Rankl in Tooth Development: Co-ordination of Odontogenesis and Osteogenesis
Ohazama, A., Courtney, J., & Sharpe, P. T. (2004) · Journal of Dental Research · doi:10.1177/154405910408300311 · Cited by 111
Weitzmann, M. N., & Pacifici, R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.068 · Cited by 98
Osteoclasts and the immune system
Nakashima, T., & Takayanagi, H. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0089-z · Cited by 94
“Blocking RANKL through OPG treatment significantly prevented bone destruction in adjuvant arthritis [73].”
BackgroundInhibition of p38 Mitogen-Activated Protein Kinase Prevents Inflammatory Bone Destruction
Mbalaviele, G., Anderson, G. D., Jones, A., Ciechi, P. D., Settle, S., Mnich, S., Thiede, M. A., Abu‐Amer, Y., Portanova, J. P., & Monahan, J. B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100362 · Cited by 97
“Although OPG injection prevents bone resorption in rodent arthritis, it had no effect on joint swelling (Kong et al., 1999a), and RANK/ RANKL role in cartilage degradation is still not known.”
BackgroundApoptosis-associated uncoupling of bone formation and resorption in osteomyelitis
Marriott, I. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00101 · Cited by 94
Komatsu, N., & Takayanagi, H. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394299-9.00002-3 · Cited by 103
“Histologically, in the RA synovium, RANKL is expressed by both synovial cells and T cells (Gravallese et al., 2000; Kong et al., 1999; Takayanagi et al., 2000a).”
Metadata
- Authors
- Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., Wong, T., Campagnuolo, G., Moran, E., Bogoch, E. R., Van, G., Nguyen, L. T., Ohashi, P. S., Lacey, D. L., Fish, E., Boyle, W. J., & Penninger, J. M.
- Affiliations
- Amgen (Canada) (CA)
- Amgen (United States) (US)
- St. Michael's Hospital (CA)
- University of Toronto (CA)
- ORCID
- Venue
- Nature
- Published
- 1999-11
- Volume
- 402
- Issue
- 6759
- Pages
- 304-309
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1677043489
- Cited by
- 1,856
- References
- 24
- Citations by year
- 2026: 17 · 2025: 33 · 2024: 36 · 2023: 33 · 2022: 25 · 2021: 36 · 2020: 47 · 2019: 43 · 2018: 38 · 2017: 59 · 2016: 64 · 2015: 82 · 2014: 80 · 2013: 85 · 2012: 77
- FWCI
- 26.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Cystic Fibrosis Foundation
- U.S. Public Health Service
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- osteoprotegerin ligand, osteoprotegerin, RANK, activated T cells, adjuvant-induced arthritis, bone loss, osteoclastogenesis, joint destruction, cartilage destruction, T cell activation, bone remodeling, osteoclasts
- MeSH terms
- Animals, Arthritis, Experimental, Bone and Bones, Bone Resorption, Carrier Proteins, Cartilage, Cells, Cultured, Glycoproteins, Humans, Lymphocyte Activation, Membrane Glycoproteins, Mice, Inbred C57BL, Rats, Inbred Lew, T-Lymphocytes, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Coculture Techniques, Mice, Rats, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.